Trials / Unknown
UnknownNCT02499016
Suprapubic Single-incision Laparoscopic Appendectomy Versus Conventional Appendectomy: a Randomized Controlled Trial
Suprapubic Single-incision Laparoscopic Appendectomy Versus Conventional Multiport Appendectomy: a Randomized Controlled Trial
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 208 (estimated)
- Sponsor
- Nanfang Hospital, Southern Medical University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Conventional laparoscopic appendectomy(CLA) is the current standard treatment. To obtain additional benefits such as a better cosmetic outcome, the investigators developed a surgical option termed suprapubic single-incision laparoscopic appendectomy (SSILA), which creates a non-visible scar, that was preliminarily shown to be feasible and safe in our previous retrospective studies To further evaluate the feasibility, safety and cosmetic results of this innovative approach, the investigators compared the outcomes of SSILA and CLA by performing a randomized controlled trial.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | suprapubic single-incision laparoscopic appendectomy | the approach of appendectomy |
Timeline
- Start date
- 2015-06-01
- Primary completion
- 2017-12-01
- Completion
- 2018-12-01
- First posted
- 2015-07-15
- Last updated
- 2015-07-15
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02499016. Inclusion in this directory is not an endorsement.